Camrelizumab, Pegaspargase and Apatinib With Radiation Therapy for Stage IE/IIE ENKTL
NCT04366128
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
Interventions
DRUG:
CAPA indution immunotherapy
Sponsor
Rong Tao